Video

Spotting the Signs of Uterine Cancer

Author(s):

Dennis R. Scribner, M.D.

While there is no test, such as a mamogram or colonoscopy, for uterine cancer, vaginal bleeding is a telltale sign of the disease.

Dennis R. Scribner, M.D., FACOG, FACS, clinical associate professor for the University of Arizona School of Medicine, Arizona Oncology, explains an important telltale sign of uterine cancer.

While there is no test for uterine cancer (such as a mammogram for breast cancer or a colonoscopy for colorectal cancer) vaginal bleeding is one of the first signs that a woman might have uterine cancer. so, Scribner suggests that women who are experiencing abnormal bleeding contact their health care providers.

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Related Content
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.
February 21st 2025

How Patients With Cancer Can Avoid Counterfeit Therapeutics Online

Dr. Megan Menon
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.
‘I’m Not Always Happy, But I’m Happy Right Now’ with Endometrial Cancer
April 15th 2021

‘I’m Not Always Happy, But I’m Happy Right Now’ with Endometrial Cancer

Jamie Cesanek
In this episode of the “CURE® Talks Cancer” podcast, Pamela Hegg details her journey with a rare form of endometrial cancer and explains how she’s able to stay positive through multiple recurrences.
Image of man with black hair.
February 3rd 2025

Rybrevant Alone and in Combo With Chemo is Efficacious in Wildtype+ mCRC

Ryan Scott
Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified metastatic colorectal cancer.
Site Logo
September 13th 2018

A Survivor and Her Running Shoes

Brielle Benyon
“I’m just a single person. I don’t have money. I don’t have political influence. What I do have is my running shoes,” she said during the interview.
Image of man with grey hair.
January 16th 2025

An Expert Breaks Down the Meaning of MRD Testing in Cancer Care

Ryan Scott
Dr. Christopher R. Flowers delved into the meaning of MRD, discussing different ways that it may be tested for in patients with various types of cancer.
Image of man with brown hair.
January 11th 2025

A Breakdown of Trial Data that Led to the Subcutaneous Opdivo FDA Approval

Ryan Scott
Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.